Episurfedicalal announced that results from a follow-up study on the Episealer knee implanant have been accepted for publication (peer-reviewed) in the Journal of Experimental Orthopaedics. The article, with the title "2-year results of middle-aged patients with two-compartment cartilage lesions in one knee treated with two patient specific metal implants", by Daniel Aaron den Toom, Markus Rieke, Allaeldin Elbadawi and Clemens Ksters, focuses on the clinical outcome from follow-up of patients treated with two implants in the same knee. The patients have been followed-up over 2-year period, and the publication will be available shortly.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.222 SEK | +3.02% | +0.23% | -77.58% |
04-24 | Episurf Medical Announces Distributor Agreement with Depuy-Synthes | CI |
04-24 | Episurf Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-77.58% | 13.39M | |
+11.57% | 128B | |
-1.53% | 11.8B | |
+54.20% | 6.65B | |
-26.20% | 6.65B | |
-33.16% | 4.19B | |
+8.26% | 3.45B | |
-20.80% | 2.46B | |
-20.72% | 1.94B | |
-22.52% | 1.75B |
- Stock Market
- Equities
- EPIS B Stock
- News Episurf Medical AB
- Episurf Announces Results from the Use of Episealer Accepted for Publication in Scientific Journal